A novel Heme oxygenase-1 inducer decreases sFlt1 production in primary placental and endothelial cells: may provide therapeutic options for preeclampsia. (#21)
Kenji Onda
1
2
,
Stephen Tong
1
,
Laura Tuohey
1
,
Fiona Brownfoot
1
,
Natalie J Hannan
1
- Translational Obstetrics Group, Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Australia, Heidelberg, Vic
- Department of Clinical Pharmocology , Tokyo University of Pharmacy and Life Sciences, School of Pharmacy, Tokyo, Japan